These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
397 related articles for article (PubMed ID: 15907526)
1. Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia. Matthai WH; Hursting MJ; Lewis BE; Kelton JG Thromb Res; 2005; 116(2):121-6. PubMed ID: 15907526 [TBL] [Abstract][Full Text] [Related]
9. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Young G; Boshkov LK; Sullivan JE; Raffini LJ; Cox DS; Boyle DA; Kallender H; Tarka EA; Soffer J; Hursting MJ Pediatr Blood Cancer; 2011 Jul; 56(7):1103-9. PubMed ID: 21488155 [TBL] [Abstract][Full Text] [Related]
10. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia. Guzzi LM; McCollum DA; Hursting MJ J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for major bleeding in patients with heparin-induced thrombocytopenia treated with argatroban: a retrospective study. Hursting MJ; Verme-Gibboney CN J Cardiovasc Pharmacol; 2008 Dec; 52(6):561-6. PubMed ID: 19057393 [TBL] [Abstract][Full Text] [Related]
12. Transitioning from argatroban to warfarin in heparin-induced thrombocytopenia: an analysis of outcomes in patients with elevated international normalized ratio (INR). Bartholomew JR; Hursting MJ J Thromb Thrombolysis; 2005 Jun; 19(3):183-8. PubMed ID: 16082605 [TBL] [Abstract][Full Text] [Related]
13. Argatroban dosing in patients with heparin-induced thrombocytopenia. Verme-Gibboney CN; Hursting MJ Ann Pharmacother; 2003; 37(7-8):970-5. PubMed ID: 12841802 [TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis. Frame JN; Rice L; Bartholomew JR; Whelton A Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232 [TBL] [Abstract][Full Text] [Related]
15. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study. Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512 [TBL] [Abstract][Full Text] [Related]
16. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices. Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371 [TBL] [Abstract][Full Text] [Related]
17. Argatroban anticoagulation during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia. Lewis BE; Matthai WH; Cohen M; Moses JW; Hursting MJ; Leya F; Catheter Cardiovasc Interv; 2002 Oct; 57(2):177-84. PubMed ID: 12357516 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia. Kiser TH; Jung R; MacLaren R; Fish DN Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293 [TBL] [Abstract][Full Text] [Related]
19. Comparison of bivalirudin and argatroban for the management of heparin-induced thrombocytopenia. Skrupky LP; Smith JR; Deal EN; Arnold H; Hollands JM; Martinez EJ; Micek ST Pharmacotherapy; 2010 Dec; 30(12):1229-38. PubMed ID: 21114390 [TBL] [Abstract][Full Text] [Related]
20. Argatroban and renal replacement therapy in patients with heparin-induced thrombocytopenia. Tang IY; Cox DS; Patel K; Reddy BV; Nahlik L; Trevino S; Murray PT Ann Pharmacother; 2005 Feb; 39(2):231-6. PubMed ID: 15632219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]